Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LVAD implant
DEVICE
2 trials
Sponsors
Abbott Medical Devices
, Palak Shah
Conditions
Heart Failure
Phase 2
Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices
Completed
NCT04865978
Palak Shah
Heart Failure
Start: 2021-12-14
End: 2023-11-07
Updated: 2024-11-14
Unknown Phase
The ARIES HeartMate 3 Pump IDE Study
Completed
NCT04069156
Abbott Medical Devices
Heart Failure
Start: 2020-07-14
End: 2023-08-10
Updated: 2025-03-27
Related Papers
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial.
2025-11-19
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy
JACC Heart Failure
2025-04-09
4 citations
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial.
2025-03-01
10 citations
Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices
JACC Heart Failure
2024-05-07
39 citations
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
2023-12-01
88 citations
Design and Rationale for the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study.
2023-11-11
5 citations